wellgistics health inc - WGRX

WGRX

Close Chg Chg %
0.40 0.00 0.13%

Open Market

0.40

0.00 (0.13%)

Volume: 208.11K

Last Updated:

Jan 22, 2026, 2:09 PM EDT

Company Overview: wellgistics health inc - WGRX

WGRX Key Data

Open

$0.39

Day Range

0.39 - 0.40

52 Week Range

N/A - N/A

Market Cap

$35.89M

Shares Outstanding

89.73M

Public Float

39.44M

Beta

-8.54

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$1.10

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

327.30K

 

WGRX Performance

1 Week
 
-2.12%
 
1 Month
 
-1.83%
 
3 Months
 
-65.47%
 
1 Year
 
N/A
 
5 Years
 
N/A
 

WGRX Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About wellgistics health inc - WGRX

Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

WGRX At a Glance

Wellgistics Health, Inc.
3000 Bayport Drive
Tampa, Florida 33607
Phone 1-844-203-6092 Revenue 18.13M
Industry Medical Distributors Net Income -6,856,226.00
Sector Distribution Services Employees N/A
Fiscal Year-end 12 / 2025
View SEC Filings

WGRX Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio N/A
Price to Book Ratio N/A
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA N/A
Enterprise Value to Sales N/A
Total Debt to Enterprise Value N/A

WGRX Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 4.84
Total Asset Turnover 0.629

WGRX Liquidity

Current Ratio 0.376
Quick Ratio 0.125
Cash Ratio 0.027

WGRX Profitability

Gross Margin 3.60
Operating Margin -33.897
Pretax Margin -37.819
Net Margin -37.819
Return on Assets -23.777
Return on Equity -357.653
Return on Total Capital -21.531
Return on Invested Capital -83.687

WGRX Capital Structure

Total Debt to Total Equity 372.844
Total Debt to Total Capital 78.851
Total Debt to Total Assets 43.795
Long-Term Debt to Equity 186.377
Long-Term Debt to Total Capital 39.416
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Wellgistics Health Inc - WGRX

Collapse All in section
All values USD millions. 2022 2023 2024 5-year trend
Sales/Revenue
- - - 18.13M
-
Sales Growth
- - - -
-
Cost of Goods Sold (COGS) incl D&A
- - - 17.48M
-
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
- - - 1.11M
-
Depreciation
- - - 67.62K
-
Amortization of Intangibles
- - - 1.05M
-
COGS Growth
- - - -
-
Gross Income
- - - 652.65K
-
Gross Income Growth
- - - -
-
Gross Profit Margin
- - - +3.60%
-
2022 2023 2024 5-year trend
SG&A Expense
- 5.25K 2.88M 6.80M
Research & Development
- - - -
-
Other SG&A
- 5.25K 2.88M 6.80M
SGA Growth
- - +54,768.63% +135.98%
-
Other Operating Expense
- - - -
-
Unusual Expense
- - - -
-
EBIT after Unusual Expense
- (5.25K) (2.88M) (6.15M)
Non Operating Income/Expense
- - - 120.37K
-
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - 15.08K 831.47K
-
Interest Expense Growth
- - - +5,413.34%
-
Gross Interest Expense
- - 15.08K 831.47K
-
Interest Capitalized
- - - -
-
Pretax Income
- (5.25K) (2.90M) (6.86M)
Pretax Income Growth
- - -55,055.89% -136.77%
-
Pretax Margin
- - - -37.82%
-
Income Tax
- - - -
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
- (5.25K) (2.90M) (6.86M)
Minority Interest Expense
- - - -
-
Net Income
- (5.25K) (2.90M) (6.86M)
Net Income Growth
- - -55,055.89% -136.77%
-
Net Margin Growth
- - - -37.82%
-
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
- (5.25K) (2.90M) (6.86M)
Preferred Dividends
- - - -
-
Net Income Available to Common
- (5.25K) (2.90M) (6.86M)
EPS (Basic)
- -0.0001 -0.0558 -0.132
EPS (Basic) Growth
- - -55,700.00% -136.56%
-
Basic Shares Outstanding
- 51.94M 51.94M 51.94M
EPS (Diluted)
- -0.0001 -0.0558 -0.132
EPS (Diluted) Growth
- - -55,700.00% -136.56%
-
Diluted Shares Outstanding
- 51.94M 51.94M 51.94M
EBITDA
- (5.25K) (2.88M) (5.03M)
EBITDA Growth
- - -54,768.57% -74.63%
-
EBITDA Margin
- - - -27.75%
-

Insider Actions for Wellgistics Health Inc - WGRX

Date Name Shares Transaction Value
Mar 26, 2025 Donald W. Anderson Director 244,720 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2025 Prashant Patel Chief Strategy Officer; Director 4,118,247 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2025 Prashant Patel Chief Strategy Officer; Director 1,500,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2025 Prashant Patel Chief Strategy Officer; Director 700,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 26, 2025 Brian Norton Chief Executive Officer 9,044,720 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 25, 2025 Rebecca M. Shanahan Director 244,720 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Mar 25, 2025 Nikul Panchal Chief Pharmacy Officer 90,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Wellgistics Health Inc in the News